Search results for "Venous Thromboembolism"


 
Results 71 - 80 of about 338 for "Venous Thromboembolism".
Sort by: Relevance | Newest | Oldest

Fixed-dose rivaroxaban appears noninferior to standard therapy for PE

Fixed-dose rivaroxaban is noninferior to standard anticoagulant therapy for pulmonary embolism (PE) and has a similar bleeding risk, a new study found.
https://acphospitalist.acponline.org/weekly/archives/2012/03/28/2.htm
28 Mar 2012

Risk for DVT, PE, bleeding after COVID-19, but low long-term VTE recurrence risk

One study found increased risk for deep venous thrombosis (DVT) for up to three months after COVID-19, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while another showed low rates of venous thromboembolism (VTE) recurrence in the year after infection.
https://acphospitalist.acponline.org/archives/2022/04/13/free/risk-for-dvt-pe-bleeding-seen-after-covid-19-long-term-risk-for-vte-recurrence-may-be-low.htm
13 Apr 2022

Pulmonary embolism detected in about 6% of patients with COPD hospitalized with acute respiratory symptoms

In a study of 740 patients with chronic obstructive pulmonary disease (COPD) hospitalized with acutely worsening respiratory symptoms at seven French hospitals, 5.9% had pulmonary embolism detected within 48 hours of admission using the revised Geneva score.
https://acphospitalist.acponline.org/weekly/archives/2021/01/13/4.htm
13 Jan 2021

PE recurrence same with vena cava filter plus anticoagulation as anticoagulation alone

Adding an inferior vena cava filter did not reduce the risk of recurrent pulmonary embolism (PE) compared to anticoagulation alone, according to a recent study of French patients hospitalized with PE.
https://acphospitalist.acponline.org/weekly/archives/2015/05/13/3.htm
13 May 2015

Systematic review compares new and old anticoagulation options for acute VTE

The benefits and risks of 8 different anticoagulation strategies for patients with venous thromboembolism (VTE), including heparin and new oral anticoagulants, were compared in a large new analysis.
https://acphospitalist.acponline.org/weekly/archives/2014/09/24/1.htm
24 Sep 2014

Wells score, negative D-dimer test can rule out pulmonary embolism in primary care patients

A Wells score of 4 or lower and a negative qualitative D-dimer test result can safely and efficiently exclude pulmonary embolism, a study found.
https://acphospitalist.acponline.org/weekly/archives/2012/10/17/6.htm
17 Oct 2012

April 19, 2023

ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2023/04/19/

December issue online and in the mail

The latest issue of ACP Hospitalist covers diabetes, gabapentinoids, high-value care, burnout, and antibiotic stewardship.
https://acphospitalist.acponline.org/weekly/archives/2019/12/11/5.htm
11 Dec 2019

Pandemic lessons, VTE prediction, and COVID-19 effects on other inpatients

One hospital reduced unnecessary labs during the pandemic, while another collected nine lessons to improve health care. Other recent studies looked at venous thromboembolism (VTE) in COVID-19 inpatients and mortality rates among patients hospitalized for other conditions during last year's surges.
https://acphospitalist.acponline.org/weekly/archives/2021/07/28/1.htm
28 Jul 2021

Iron/EPO combination beats other options for reducing transfusions

A review looked at trials comparing erythropoiesis-stimulating agents (EPO), iron, combination therapy with iron and EPO, hypoxia-inducible factor prolyl hydroxylase inhibitor, or vitamin D3 with controls on rates of red blood cell transfusion in the ICU.
https://acphospitalist.acponline.org/archives/2023/11/22/ironepo-combination-beats-other-options-for-reducing-icu-transfusions.htm
22 Nov 2023

Result Page: Prev   3   4   5   6   7   8   9   10   11   12   Next